US Patent Issued to GENEMATRIX on Sept. 9 for "Structurally modified chimeric polypeptide of human papillomavirus, recombinant protein comprising same polypeptide, and use of same protein" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,214, issued on Sept. 9, was assigned to GENEMATRIX INC. (Seongnam-si, South Korea).

"Structurally modified chimeric polypeptide of human papillomavirus, recombinant protein comprising same polypeptide, and use of same protein" was invented by Soo Ok Kim (Seoul, South Korea), Suk Joon Kim (Seongnam-si, South Korea), Sun Pyo Hong (Seoul, South Korea), Jin Kim (Seoul, South Korea), Sang Hyun Lee (Seongnam-si, South Korea) and Sun Ok Jang (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a chimeric recombinant protein having a therapeutic effect on cervical cancer by fusing genetic modified E6 and E7, w...